Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

To help with COPD flare-ups, you may consider a medication inhaler, antibiotics, oxygen therapy, and hospital care. Your healthcare team can best advise you on treatment for COPD exacerbations.

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

If you're not paying close attention, the first stage can be easy to miss. COPD treatment goal is to help you breathe easier and help regular activities. Medications along with lifestyle ...

Conclusions: COPD is a progressive disease, and available treatment options provide limited efficacy. Given its unique mechanism of action and improved adverse effect profile compared with ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic ...

Participants were aged 40 to 80 years with moderate to very severe COPD diagnosed for at least 12 months. The patients were randomly assigned 1:1 to tezepelumab 420 mg or placebo subcutaneously. The ...

While COPD is not curable, it is a preventable and treatable illness. The earlier you start treatment, the better your prognosis. COPD is often asymptomatic until significant damage to the lungs has ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients ...

A 3 mg dose of ensifentrine was linked to improved FEV1, dyspnea, and quality of life in patients with COPD, with few treatment-emergent adverse events. Ensifentrine is a promising supplementary ...